OVARIAN CARCINOSARCOMA
Clinical trials for OVARIAN CARCINOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CARCINOSARCOMA trials appear
Sign up with your email to follow new studies for OVARIAN CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to drain ovarian Cancer's fluid trap
Disease control Recruiting nowThis study tests whether adding an experimental drug (APL-2) to standard immunotherapy (pembrolizumab) and a targeted therapy (bevacizumab) works better than bevacizumab alone for recurrent ovarian, fallopian tube, or peritoneal cancer that causes fluid buildup. About 60 adults w…
Matched conditions: OVARIAN CARCINOSARCOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 26, 2026 08:37 UTC
-
New pill takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental pill, VLS-1488, in people with advanced solid tumors that have not responded to other treatments. The drug works by blocking a protein that helps cancer cells divide. The trial has two parts: first finding a safe dose, then checking if it shrinks …
Matched conditions: OVARIAN CARCINOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New hope for rare, deadly cancer: drug combo trial launches
Disease control Recruiting nowThis study tests whether a combination of two drugs (dostarlimab and niraparib) works better than standard chemotherapy for women with a rare and aggressive cancer called carcinosarcoma of the uterus or ovary that has spread or come back. About 138 participants will be randomly a…
Matched conditions: OVARIAN CARCINOSARCOMA
Phase: PHASE2, PHASE3 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated May 20, 2026 11:55 UTC